7 Clinical Trials for: Drug: Guanfacine Hydrochloride Extended Release, Page 1 of Results

1
Completed
Efficacy and Safety of SPD503 in Combination With Psychostimulants
Condition(s): ADHD
2
Recruiting
Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
Condition(s): Attention-Deficit/Hyperactivity Disorder
3
Not yet recruiting
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
Condition(s): Attention-Deficit/Hyperactivity Disorder
4
Not yet recruiting
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
Condition(s): Attention-Deficit/Hyperactivity Disorder
5
Not yet recruiting
Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
Condition(s): Attention Deficit Disorder With Hyperactivity
6
Completed
A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers
Condition(s): Healthy
7
Completed
A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers
Condition(s): Healthy

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

Page 1 of Clinical Trials for Drug: Guanfacine Hydrochloride Extended Release, 7 Total Matches

Clinical Trials Authorship and Review